UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract infections ... Enterococcus faecalis, Klebsiella pneumoniae, and ...

GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract infections ... like Escherichia coli, Klebsiella pneumoniae, Citrobacter ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly ... by bacteria including E. coli, Klebsiella pneumoniae, Citrobacter ...

GSK’s oral antibiotic ... coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis. More than half of women are affected by UTIs, common ...

as it is the first new class of oral antibiotics for uUTIs in nearly three decades. In trials, the drug was effective against common UTI-causing bacteria, including Escherichia coli, Klebsiella ...

A new antibiotic ... Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis. More than half of all women will contract this kind of UTI in ...

Antibiotic resistance is a serious threat to public health. When antibiotics don't work, we risk not being able to treat many types of infections and people who would previously have been cured, can ...

The U.S. Food and Drug Administration just approved the first new antibiotic to treat urinary tract infections in nearly three decades ... UTIs caused by bacteria including E. coli, Klebsiella ...